Page last updated: 2024-09-05

delta(9-11)-tetrahydrocannabinol and am 251

delta(9-11)-tetrahydrocannabinol has been researched along with am 251 in 1 studies

*AM 251: an analog of SR141716A; structure given in first source [MeSH]

*AM 251: an analog of SR141716A; structure given in first source [MeSH]

Compound Research Comparison

Studies
(delta(9-11)-tetrahydrocannabinol)
Trials
(delta(9-11)-tetrahydrocannabinol)
Recent Studies (post-2010)
(delta(9-11)-tetrahydrocannabinol)
Studies
(am 251)
Trials
(am 251)
Recent Studies (post-2010) (am 251)
19069481507

Protein Interaction Comparison

ProteinTaxonomydelta(9-11)-tetrahydrocannabinol (IC50)am 251 (IC50)
Cannabinoid receptor 1Homo sapiens (human)0.0892

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engler, C; Feuerstein, TJ; Steffens, M; Zentner, J1

Other Studies

1 other study(ies) available for delta(9-11)-tetrahydrocannabinol and am 251

ArticleYear
Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex.
    British journal of pharmacology, 2004, Volume: 141, Issue:7

    Topics: Adenylyl Cyclases; Amygdala; Animals; Arachidonic Acids; Benzoxazines; Binding Sites; Colforsin; Cyclic AMP; Cyclohexanols; Dopamine; Dronabinol; Electric Stimulation; Endocannabinoids; Female; Humans; Ligands; Male; Morpholines; Naphthalenes; Neocortex; Piperidines; Polyunsaturated Alkamides; Potassium; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Synaptosomes; Tetrodotoxin; Tritium

2004